Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer gene therapy

Showing results (1-10 of 3,035) with videos related to

Pageof 304
Sort By:
Cancer Gene Therapy|June 27, 2024
Correction: H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2Eunbi Lee, Yoon Jung Park, Anders M Lindroth
Cancer Gene Therapy|June 29, 2022
Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cellsXiaobin Wang, Xiaoyu Liu, Huihan Wang
Cancer Gene Therapy|November 22, 2022
Glimmers of hope for targeting oncogenic KRAS-G12DDaolin Tang, Rui Kang
Cancer Gene Therapy|December 9, 2022
FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid raftsBin Li, Zuo Ding, Ozlem Calbay, et al.
Cancer Gene Therapy|December 9, 2022
miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2Zhijiao Song, Caihe Liao, Liqun Yao, et al.
Cancer Gene Therapy|October 13, 2020
Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligandJunhui Yu, Kui Yang, Jianbao Zheng, et al.
Cancer Gene Therapy|June 11, 2021
Suppression of tumor growth and metastasis in Shkbp1 knockout miceQing Liu, Haobin Li, Mingming Yang, et al.
Cancer Gene Therapy|January 4, 2023
MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancerQian Li, Dongdong Tong, Xintao Jing, et al.
Cancer Gene Therapy|December 20, 2022
Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancerPreeti Borde, Nicola Cosgrove, Sara Charmsaz, et al.
Cancer Gene Therapy|June 13, 2022
Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibitionChandra C Ghosh, Kara R Heatherton, Kyle P O' Connell, et al.
Pageof 304

Showing results (1-10 of 3,035) with videos related to

Sort By:
Pageof 304
Cancer Gene Therapy|June 27, 2024
Correction: H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2Eunbi Lee, Yoon Jung Park, Anders M Lindroth
Cancer Gene Therapy|June 29, 2022
Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cellsXiaobin Wang, Xiaoyu Liu, Huihan Wang
Cancer Gene Therapy|November 22, 2022
Glimmers of hope for targeting oncogenic KRAS-G12DDaolin Tang, Rui Kang
Cancer Gene Therapy|December 9, 2022
FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid raftsBin Li, Zuo Ding, Ozlem Calbay, et al.
Cancer Gene Therapy|December 9, 2022
miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2Zhijiao Song, Caihe Liao, Liqun Yao, et al.
Cancer Gene Therapy|October 13, 2020
Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligandJunhui Yu, Kui Yang, Jianbao Zheng, et al.
Cancer Gene Therapy|June 11, 2021
Suppression of tumor growth and metastasis in Shkbp1 knockout miceQing Liu, Haobin Li, Mingming Yang, et al.
Cancer Gene Therapy|January 4, 2023
MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancerQian Li, Dongdong Tong, Xintao Jing, et al.
Cancer Gene Therapy|December 20, 2022
Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancerPreeti Borde, Nicola Cosgrove, Sara Charmsaz, et al.
Cancer Gene Therapy|June 13, 2022
Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibitionChandra C Ghosh, Kara R Heatherton, Kyle P O' Connell, et al.
Pageof 304